These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 1310410)

  • 1. Interactions between anticollagen antibodies and chondrocytes.
    Takagi T; Jasin HE
    Arthritis Rheum; 1992 Feb; 35(2):224-30. PubMed ID: 1310410
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interactions of synovial fluid immunoglobulins with chondrocytes.
    Takagi T; Jasin HE
    Arthritis Rheum; 1992 Dec; 35(12):1502-9. PubMed ID: 1472127
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characteristics of anti-type II collagen antibody binding to articular cartilage.
    Jasin HE; Noyori K; Takagi T; Taurog JD
    Arthritis Rheum; 1993 May; 36(5):651-9. PubMed ID: 8489543
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Binding characteristics of antitype II collagen antibody to the surface of diseased human cartilage as a probe for tissue damage.
    Noyori K; Koshino T; Takagi T; Okamoto R; Jasin HE
    J Rheumatol; 1994 Feb; 21(2):293-6. PubMed ID: 8182639
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A fibronectin fragment induces type II collagen degradation by collagenase through an interleukin-1-mediated pathway.
    Yasuda T; Poole AR
    Arthritis Rheum; 2002 Jan; 46(1):138-48. PubMed ID: 11817586
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Repair characteristics of the articular cartilage surface following acute inflammatory arthritis.
    Noyori K; Jasin HE
    J Rheumatol; 1994 Sep; 21(9):1731-3. PubMed ID: 7799358
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neutral proteinases from articular chondrocytes in culture. I. A latent collagenase that degrades human cartilage type II collagen.
    Malemud CJ; Norby DP; Sapolsky AI; Matsuta K; Howell DS; Moskowitz RW
    Biochim Biophys Acta; 1981 Feb; 657(2):517-29. PubMed ID: 6260204
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proteoglycan- and collagen-degrading enzymes from human interleukin 1-stimulated chondrocytes from several species: proteoglycanase and collagenase inhibitors as potentially new disease-modifying antiarthritic agents.
    DiPasquale G; Caccese R; Pasternak R; Conaty J; Hubbs S; Perry K
    Proc Soc Exp Biol Med; 1986 Nov; 183(2):262-7. PubMed ID: 3020566
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Destructive effects of murine arthritogenic antibodies to type II collagen on cartilage explants in vitro.
    Crombie DE; Turer M; Zuasti BB; Wood B; McNaughton D; Nandakumar KS; Holmdahl R; Van Damme MP; Rowley MJ
    Arthritis Res Ther; 2005; 7(5):R927-37. PubMed ID: 16207334
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Susceptibility of interstitial rabbit collagens to rabbit articular chondrocyte collagenase.
    Kresina TF; Malemud CJ
    Coll Relat Res; 1984 Dec; 4(6):453-65. PubMed ID: 6098405
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An arthritogenic monoclonal antibody to type II collagen, CII-C1, impairs cartilage formation by cultured chondrocytes.
    Amirahmadi SF; Pho MH; Gray RE; Crombie DE; Whittingham SF; Zuasti BB; Van Damme MP; Rowley MJ
    Immunol Cell Biol; 2004 Aug; 82(4):427-34. PubMed ID: 15283854
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanisms of disruption of the articular cartilage surface in inflammation. Neutrophil elastase increases availability of collagen type II epitopes for binding with antibody on the surface of articular cartilage.
    Jasin HE; Taurog JD
    J Clin Invest; 1991 May; 87(5):1531-6. PubMed ID: 1708782
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunological detection of type II collagen degradation: use in the evaluation of anti-arthritic therapies.
    Chichester CO; Barrach HJ; Srinivas GR; Mitchell P
    J Pharm Pharmacol; 1996 Jul; 48(7):694-8. PubMed ID: 8866331
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Arthritogenic anti-type II collagen antibodies are pathogenic for cartilage-derived chondrocytes independent of inflammatory cells.
    Amirahmadi SF; Whittingham S; Crombie DE; Nandakumar KS; Holmdahl R; Mackay IR; van Damme MP; Rowley MJ
    Arthritis Rheum; 2005 Jun; 52(6):1897-906. PubMed ID: 15934095
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of anchorin CII, a 31,000-mol-wt membrane protein, in the interaction of chondrocytes with type II collagen.
    Mollenhauer J; Bee JA; Lizarbe MA; von der Mark K
    J Cell Biol; 1984 Apr; 98(4):1572-9. PubMed ID: 6325473
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of a specific antiserum to rabbit stromelysin and demonstration of the synthesis of collagenase and stromelysin by stimulated rabbit articular chondrocytes.
    Murphy G; Hembry RM; Reynolds JJ
    Coll Relat Res; 1986 Oct; 6(4):351-63. PubMed ID: 3028709
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cell attachment, collagen binding, and receptor analysis on bovine articular chondrocytes.
    Reid DL; Aydelotte MB; Mollenhauer J
    J Orthop Res; 2000 May; 18(3):364-73. PubMed ID: 10937622
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lack of response of rat chondrosarcoma chondrocytes to interleukin-1 to produce proteoglycan- and collagen-degrading enzymes.
    DiPasquale G; Caccese R; Pasternak R; Caputo CB; Conaty J; Hubbs S
    Res Commun Chem Pathol Pharmacol; 1986 Jun; 52(3):333-9. PubMed ID: 3526479
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sites of collagenase cleavage and denaturation of type II collagen in aging and osteoarthritic articular cartilage and their relationship to the distribution of matrix metalloproteinase 1 and matrix metalloproteinase 13.
    Wu W; Billinghurst RC; Pidoux I; Antoniou J; Zukor D; Tanzer M; Poole AR
    Arthritis Rheum; 2002 Aug; 46(8):2087-94. PubMed ID: 12209513
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation by interleukin 1 and tumor necrosis factor alpha of production of collagenase, tissue inhibitor of metalloproteinases and collagen types in differentiated and dedifferentiated articular chondrocytes.
    Lefebvre V; Peeters-Joris C; Vaes G
    Biochim Biophys Acta; 1990 May; 1052(3):366-78. PubMed ID: 2162214
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.